[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU641123B2 - Single-use syringe - Google Patents

Single-use syringe Download PDF

Info

Publication number
AU641123B2
AU641123B2 AU34404/89A AU3440489A AU641123B2 AU 641123 B2 AU641123 B2 AU 641123B2 AU 34404/89 A AU34404/89 A AU 34404/89A AU 3440489 A AU3440489 A AU 3440489A AU 641123 B2 AU641123 B2 AU 641123B2
Authority
AU
Australia
Prior art keywords
barrel
shank
base
needle
syringe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU34404/89A
Other versions
AU3440489A (en
Inventor
Konrad George Alter
Jennifer Dale Griffiths
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nujenko Pty Ltd
Original Assignee
Nujenko Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/263,705 external-priority patent/US4919652A/en
Application filed by Nujenko Pty Ltd filed Critical Nujenko Pty Ltd
Priority to AU34404/89A priority Critical patent/AU641123B2/en
Publication of AU3440489A publication Critical patent/AU3440489A/en
Application granted granted Critical
Publication of AU641123B2 publication Critical patent/AU641123B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Description

ORI DATE 24/11/89 AOJP i'ATE 21/12/89 APPLN. ID 34404 89 PCT NUMBER PCT/AU89/00115 PCrI W~fls 8Ji *ssf L YIntemat l Burea International Bureau INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (51) International Patent Classification 4 (11) International Publication Number: WO 89/10151 A61M 5/315, 5/32, 5/34 Al (43) International Publication Date: 2 November 1989 (02.11.89) (21) International Application Number: PCT/AU89/00115 (81) Designated States: AT, AT (European patent), AU, BB, BE (European patent), BF (OAPI patent), BG, BJ (OA- (22) International Filing Date: 22 March 1989 (22.03.89) PI patent), BR, CF (OAPI patent), CG (OAPI patent), CH, CH (European patent), CM (OAPI patent), DE, DE (European patent), DK, FI, FR (European patent), Priority data: GA (OAPI pateat), GB, GB (European patent), HU, IT PI 7792 18 April 1988 (18.04.88) AU (European patent), JP, KP, KR, LK, LU, LU (European 263,705 28 October 1988 (28.10.88) US patent), MC, MG, ML (OAPI patent), MR (OAPI patent), MW, NL, NL (European patent), NO, RO, SD, SE, SE (European patent), SN (OAPI patent), SU, TD (71)Applicant: NUJENKO PTY LTD [AU/AU]; 74 McCoy (OAPI patent), TG (OAPI patent).
Street, Myaree, W.A. 6154 (AU).
(72) Inventors: ALTER, Konrad, George 55 Kennedy Street, Published Maylands, W.A. 6051 GRIFFITHS, Jennifer, With international search report.
Dale 25 St. Leonard's Avenue, West Leederville, W.A. With amended claims.
6007 (AU).
(74) Agents: HARWOOD, Errol, John et al.; Wray Asso- 6 4 ciates, P.O. Box 6292, East Perth, W.A. 6004 (AU).
(54)Title: SINGLE-USE SYRINGE (57) Abstract A syringe which is intented for use ,nly once and which can be redered useless ,f;er use. The syringe comprises a barrel (11) and a plunger (13) receivable in the barrel and movable therealong. The plunger (13) includes a shank (53) which is selectively deformable to render the plunger inoperable. The shank includes a weakened section (59) at which it can be fractured to effect deformation of the shank.
1 SINGLE-USE SYRINGE THIS INVENTION relates to syringes and more particularly syringes intended for single use only.
Throughout the specification the term "syringe" shall be taken to include a hypodermic syringes and other device incorporating a needle for injecting fluid into, or extracting fluid from, a body.
Syringes are commonly intended for single use only and disposal after 'such use, as any subsequent use carries with it the possibility of transmission of infection by the needle of the syringe. Nevertheless there are instances where single-use syringes are used again contrary to advice from health authorities, and there is a need for a syringe which can be used only once.
It is an object of this invention to provide a syringe which can be effectively rendered in operative after use.
In one form the invention resides in a syringe comprising a barrel, a plunger receivable in the barrel and movable therealong, the plunger including a shank, said shank having a selectively deformable portion for rendering the plunger inoperable, and said barrel including a side wall r o: having an aperture opening onto an end of the barrel beyond which the shank extends, said aperture being adapted to receive said deformable portion of the shank upon lateral deflection of the outer end portion of the shank, during deformation.
Preferably the shank includes a weakened section at the deformable portion which can be fractured to effect deformation of the shank.
2 Preferably, the weakened section of the shank is adapted to be fractured upon application of a predetermined bending force to the shank.
Conveniently, the weakened section is of reduced cross-sectional area in comparison to the remainder of the shank. Alternatively or additionally, the weakened section may include at least one cavity or other means for providing a zone of weakness in the weakened section.
Preferably, said portion of the shank receivable in said aperture is a portion of the weakened section of the shank.
Preferably, said aperture in the side wall of the barrel is configured to inhibit removal of the shank once it is received fully within the aperture.
In additional to preventing reuse of a syringe, it is beneficial to provide the syringe with a feature whereby the.needle can be retracted into the barrel after use.
The purpose of retracting the needle into the barrel is to ensure that a person handling the syringe is protected from inadvertent wounding by the contaminated needle.
This reduces the likelihood of transmission of infection by a contaminated needle.
S"To this end, the syringe preferably comprises a needle portion having a base and a needle mounted on the base and projecting from the base, securing means for releasably securing the base of the needle portion to the barrel with the needle extending outwardly from the barrel and the bore in the needle communicating with the interior of the i uf% On/l I r TIVJ 0 *y /ViAi 3 YLI/AUoY/UUI1 barrel, said securing means being arranged to effect release of said base from the barrel upon rotation of the base relative to the barrel, an engaging means for releasably engaging the plunger with said base whereby when so engaged with the base the plunger can be rotated to effect release of the base from the barrel and then be retracted to move the needle into-the region within the barrel.
Preferably, the securing -eans comprises screw means for threadingly engaging the base to the barrel. The screw means preferably comprises a multiple thread.
The engaging means preferably comprises a socket provided on the base of the needle portion and a projection provided on the plunger for reception in the socket and engagement therewith.
Preferably, the socket is aligned with the needle so as to provide communication between the needle and the interior of the barrel.
Engagement between the socket and the projection is effected by pushing the plunger to insert the projection into the socket.
The invention will be better understood by reference to the following description of one specific embodiment thereof as shown in the accompanying drawings in which:- Fig. 1 is a sectional view of a syringe according to the embodiment with the needle portion shown secured to the barrel; Fig. 2 is a view similar to Fig. 1 except that the needle portion is shown detached from the barrel and ,wV\ aft inIi DPT/A I llonnni I TVY.J U1 V )AU J- 4 V- r0OUUl llI partially retracted into the barrel; Fig. 3 is a sectional elevational view of the syringe shown during drawing of fluid into the barrel for injection into a patient at a later stage; Fig. 4 is a sectional elevational view of the syringe shown prior to injection of the fluid contained in the barrel; Fig. 5 is a sectional elevational view of the syringe shown after injection of the fluid has been completed and prior to retraction of the needle into the barrel; Fig. 6 is a sectional elevational view of the syringe shown after retraction of the needle into the barrel and prior to deformation of the shank of the plunger; *Fig. 7 is a view similar to Fig. 6 with the exception that the shank of the plunger is shown partially fractured; Fig. 8 is a sectional elevational view of the syringe shown after fracturing of the shank (with the outer section of the shank shown removed for the purpose of clarity of illustration); Fig. 9 is a sectional elevational view of the barrel of the syringe; Fig. 10 is an elevational view of the plunger of the syringe; and Fig. 11 is a partly sectioned elevational view of the needle.portion of the syringe.
The embodiment shown in the drawings is directed to a hypodermic syringe intended for single use only and then disposal. The syringe comprises a syringe barrel 11, a plunger 13, a needle portion 15 and a filling needle portion 17.
WO 89/10151 5- PC/AU89/00115 The barrel 11 has a nozzle 19 at the distal end 21 thereof and is open at the proximal end 23. A flange 25 is formed around the opening at the proximal end 23 of the barrel to provide a means by which a user may grip the barrel while using the syringe. The nozzle 19 defines an axial passage 27 one end of which communicated with the interior of the barrel while the other end opens to the exterior of the barrel. An internal thread formation 29 comprising multiple threads is provided on the wall of the passage 27, the purpose of which will become apparent later.
The needle portion 15 is detachably mountable on the barrel. The needle portion includes a base 31 and a hollow needle 33 mounted onto the base. The needle 33 has a sharp-pointed end 35 opposite the base 11. The base 31 is adapted to be received within the axial passage 27 defined within the nozzle of the barrel and has protrusions 28 for threadingly engaging the internal thread formation 29 provided on the wall of the passage 27.
The base 31 is hollow and when engaged in position within the nozzle of the barrel provides for fluid communication between the hollow needle 33 and the interior of the barrel.
When the needle portion 15 is to be mounted onto the barrel 11, it is inserted into the barrel through the opening at the proximal end 23 and advanced along the barrel and into the axial passage 27 of the nozzle where the base can be threadedly engaged with the nozzle.
The base 31 is provided with a hub 37 which is adapted to receive the filling needle portion. The filling needle wr\go/inIeI VT 0 O 'I Zv*J 6 r1IAUY//JUU1 portion is intended to locate over the hollow needle 33 and is used to draw fluid out of a vial or other container and into the syringe. The filling needle portion includes a base 39 which is adapted for location on the hub 37 and a hollow needle 41 which can be received around the hollow needle 33. The hollow needle 41 hav a sharp-pointed end 43 which extends beyond the sharp-pointed end 35 of the needle 33, as shown in the drawings. The filling needle portion 17 is fitted into position on the needle portion when injection fluid is to be drawn into the syringe and is removed after the filling operation, the needle portion 15 being used in the injection stage. The purpose of the filling needle portion 17 is to be maintain the sterile state of the needle portion 15 during the filling operation.
The plunger 13 comprises a piston 51 and a shank 53. The piston 51 is received in the syringe barrel 11 and is in sliding and sealing engagement with the barrel. The shank 53 is connected to the piston 51 and extends out through the opening at the proximal end of the syringe barrel.
The outer end of the shank 53 has a flange 55 to facilitate manual operation of the plunger.
The shank 53 is of a generally cruciform shape in cross-section except for a weakened section 57 at a region along the length of the shank. In the illustrated embodiment, the weakened section is located towards the piston end of the shank. The weakened section 57 is of reduced width in relation to the remainder of the shank and is provided with recesses 59 in its surface to enhance its weakened condition. The purpose of the weakened section 57 is to allow the shank to be fractured upon the application of a bending force to it. Fracturing of the shank effectively renders the plunger inoperable.
WO 89/10151 -7- PCT/AU89/00115 A cavity 58 is provided in the shank and opens onto the free end thereof for storage of the filling needle portion 17 after use.
An aperture 59 as provided in the side wall of the syringe barrel 11 and opens onto the proximal end 23 of the syringe barrel. The purpose of the aperture is to receive portion of the weakened section 57 of the shank 53 upon lateral deflection of the shank as it is being fractured.
The aperture is of a configuration which inhibits removal of the shank from the aperture once received fully therein; in this embodiment such configuration is of generally keyhole shape.
It is preferably, although not essential, that the weakened section 57 of the shank be constructed such that the shank remains intact after fracturing rather than separating into pieces, as this avoids the need to dispose of the separate pieces. It will be noted that Fig. 8 of the drawings shows the outer portion of the shank removed; this has been done for the sole purpose of illustrating the weakened section 57 received within the aperture 59 and is not intended to indicate that the shank separates into pieces at the weakened section.
The face of the piston opposite the shank is provided with an axial projection 61 adapted for reception in a socket 63 defined within the hollow base 31 of the needle portion The axial projection 61 is of generally conical form and the socket 63 is of complementary shape to snugly receive the projection. The tapered surfaces of the projection 61 and the socket 63 are provided with splines and 67 respectively which mesh when the projection 61 is received within the socket 63. With the projection 61 WORO /101 Pr I A OfSn, I T V 8 T~I/AU/0UoUUIJ1 received in the socket 63, rotational torque produced by rotating the plunger about its longitudinal axis is transmitted through the projection and socket to the base 31 of the needle portion. The rotational torque transmitted to the base 31 of the needle portion effects rotation of the base to unscrew the needle portion from the nozzle. Once the needle portion has been unscrewed from the nozzle, withdrawal of the plunger retracts the needle portion into the barrel Operation of the syringe will now be described in relation to Figs. 3 to 8 of the accompanying drawings. :Fluid for injection into the body of a patient is drawn into the syringe with the filling needle portion 17 in position, by retracting the plunger 13, as shown in Fig. 3. The filling needle portion is then removed from around the needle portion 15 and stored in the cavity 58 within the free end of the shank. The syringe is at this stage in readiness for injection of the fluid previously drawn into the barrel, a! shown in Fig. 4. The needle 33 is inserted into the body of the patient and the plunger pushed inwardly thereby to force the injection fluid through the hollow base 31 and needle 33 into the body of the patient.
As the piston 51 approaches the distal end of the syringe barrel 11 towards the end of the injection stage, the projection 61 enters the socket 63. By the end of the injection stage, the projection is snugly received in the socket, as shown in Fig. 5. The plunger is then rotated in the direction appropriate to unscrew the protrusions 28 on the base 31 from the thread formation 29 in the nozzle.
After the base has been unscrewed from the nozzle, the plunger (which remain connected to the base of the needle portion is retracted to withdraw the needle portion into the syringe barrel, as shown in Fig. 6. The plunger is then positioned such that the weakened section 57 of WO 89/10151 PCT/AU89/00115 the shank 53 is located adjacent the aperture 59 in the syringe barrel and a bending force is applied to the shank in the direction towards the aperture, as shown in Fig. 7.
The resulting lateral deflection of the shank causes the weakened section to fracture and enter the aperture, as shown in Fig. 8. The keyhole shape of the aperture serves to inhibit removal of the shank from the aperture and so the plunger is effectively locked to the syringe barrel, with the needle 33 being confined within the barrel where it is not exposed for inadvertent puncturing of the patient or any person handling the syringe.
Because the shank of the plunger has been fractured, the syringe cannot be readily used -again and thus the possibility of transmission of infection by the contaminated needle is avoided.
It should be appreciated that the scope of the invention is not limited to the scope of the embodiment described.

Claims (8)

1. A syringe comprising a barrel, a plunger receivable in the barrel and movable therealong, the plunger including a shank, said shank having a selectively deformable portion for rendering the plunger inoperable, and said barrel including a side wall having an aperture opening onto an end of the barrel beyond which the shank extends, said aperture being adapted to receive said deformable portion of the shank upon lateral deflection of the outer end portion of the shank, during deformation.
2. A syringe according to claim 1 wherein the shank includes a weakened section at the deformable portion which can be fractured upon deformation of the shank.
3. A syringe according to claim 2 wherein the weakened section of the shank is adapted to be fractured upon application of a predetermined bending force to the shank.
4. A syringe according to claim 2 or 3 wherein the weakened section is of reduced cross-sectional area in comparison to the remainder of the shank. A syringe according to claim 2, 3 or 4 wherein the weakened section includes at least one cavity or other means for providing a zone of weakness in the weakened S"section.
6. A syringe according to any one of claims 2 to wherein said portion of the shank receivable in said aperture is a portion of the weakened section of the shank. q i t ft f
11- 7. A syringe according to any one of the preceding claims wherein the aperture in the side wall of the barrel is configured to inhibit removal of the shank once it is received fully within the aperture. 8. A syringe according to claim 7 wherein the aperture is of generally keyhole shape. 9. A syringe according to any one of the preceding clairz' further comprising a needle portion having a base and a needle mounted on the base and projecting from the base, securing means for releasably securing the base of the needle portion to the barrel with the needle extending outwardly from the barrel and the bore in the needle communicating with the interior of the barrel, said securing means being arranged to effect release of said base from the barrel upon rotation of the base relative to the barrel, and engaging means for releasably engaging the plunger with said base whereby when so engaged with the base the plunger can be rotated to effect release of the base from the barrel and then be retracted to move the needle into the region within the barrel. 10. A syringe according to claim 9 t a the securing means comprises screw means for threadingly engaging the S.base to the barrel. Stee 11. A syringe according to claim 9 or 10 wherein the engaging means comprises a socket provided on the base of :the needle portion and a projection provided on the :plunger for reception in the socket and engagement Stherewith.
12. A syringe according to claim 11 wherein the socket is aligned with the needle so as to provide communication between the needle and the interior of the barrel. "1 7 12
13. A syringe substantially as herein described with reference to the accompanying drawings. a Ca 9. 9 9 a 9e Ca. C. 4*6* jai
AU34404/89A 1988-04-18 1989-03-22 Single-use syringe Ceased AU641123B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU34404/89A AU641123B2 (en) 1988-04-18 1989-03-22 Single-use syringe

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPI779288 1988-04-18
AUPI7792 1988-04-18
US07/263,705 US4919652A (en) 1988-10-28 1988-10-28 Syringe
US263705 1988-10-28
AU34404/89A AU641123B2 (en) 1988-04-18 1989-03-22 Single-use syringe

Publications (2)

Publication Number Publication Date
AU3440489A AU3440489A (en) 1989-11-24
AU641123B2 true AU641123B2 (en) 1993-09-16

Family

ID=27153595

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34404/89A Ceased AU641123B2 (en) 1988-04-18 1989-03-22 Single-use syringe

Country Status (1)

Country Link
AU (1) AU641123B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8287491B2 (en) 2008-11-26 2012-10-16 Becton, Dickinson And Company Single-use auto-disable syringe

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4747830A (en) * 1986-04-28 1988-05-31 Gloyer Walter W Anti-stick contagion free disposable hypodermic safety syringe
AU1143688A (en) * 1987-02-12 1988-08-18 Habley Medical Technology Corporation Anti-needle strike and anti-drug abuse syringe
AU1308888A (en) * 1987-03-13 1988-09-22 Habley Medical Technology Corporation Disease control syringe having a retractable needle

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4747830A (en) * 1986-04-28 1988-05-31 Gloyer Walter W Anti-stick contagion free disposable hypodermic safety syringe
AU1143688A (en) * 1987-02-12 1988-08-18 Habley Medical Technology Corporation Anti-needle strike and anti-drug abuse syringe
AU1308888A (en) * 1987-03-13 1988-09-22 Habley Medical Technology Corporation Disease control syringe having a retractable needle

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8287491B2 (en) 2008-11-26 2012-10-16 Becton, Dickinson And Company Single-use auto-disable syringe
US9205205B2 (en) 2008-11-26 2015-12-08 Becton, Dickinson And Company Single-use auto-disable syringe

Also Published As

Publication number Publication date
AU3440489A (en) 1989-11-24

Similar Documents

Publication Publication Date Title
US4919652A (en) Syringe
US5180370A (en) Safety hypodermic syringe with retractable needle
CA2135099C (en) Surgical instrument for impact insertion of an intraosseous trocar-needle
AU621353B2 (en) Safety syringe
AU667296B2 (en) Syringe unit
US6416323B1 (en) Aspirating dental syringe with needle shield
US4932939A (en) Safety syringe
US6036674A (en) Retracting needle syringe
US6221052B1 (en) Retracting needle syringe
JPH05504691A (en) Syringe with replaceable and retractable needle platform
CA2063572A1 (en) Disposable hypodermic syringe with retractable needle
US5217436A (en) Remote cannula removal cartridge syringe
EP0426672B1 (en) Single-use syringe
WO1988006463A1 (en) Hypodermic needle and case assembly
JP2005511154A (en) Safety syringe with reusable main parts, method for discarding needle into container, and container for disposable parts
GB2271934A (en) Safety syringe
EP1237600B1 (en) Improvements in or relating to hypodermic syringes
AU641123B2 (en) Single-use syringe
US4968304A (en) Syringe
WO1990004424A1 (en) Single use syringe
CA2129133A1 (en) Syringe
US20050033228A1 (en) Disposable safety syringe
WO1989010150A1 (en) Syringe and protective needle sheath
KR920002310Y1 (en) Medical syringe
DE3939201C2 (en)